MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition

…, JM Ellis, LA Hyde, Y Lin, CG Markgraf… - … of Pharmacology and …, 2015 - ASPET
… The reaction was allowed to progress at 25C for 1 hour. The reaction was then stopped by …
for 20 minutes at 4C. Supernatants were then removed for subsequent Western blot analyses. …

Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats

CG Markgraf, EJ Green, BE Hurwitz, E Morikawa… - Brain research, 1992 - Elsevier
Rats were subjected to either right proximal middle cerebral artery (MCA) occlusion or sham
operation, and examined for an extendend period on a battery of tests designed to measure …

Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats

CG Markgraf, NL Velayo, MP Johnson, DR McCarty… - Stroke, 1998 - Am Heart Assoc
… Remarkably, in the present study Markgraf and coworkers demonstrated a 6-hour therapeutic
window for calpain inhibition in a rat model of focal stroke. Although MDL 28,170 is a …

LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits

…, X Liu, ML Maddess, C Markgraf… - Science translational …, 2020 - science.org
The kinase-activating mutation G2019S in leucine-rich repeat kinase 2 (LRRK2) is one of the
most common genetic causes of Parkinson’s disease (PD) and has spurred development …

Comparative histopathologic consequences of photothrombotic occlusion of the distal middle cerebral artery in Sprague-Dawley and Wistar rats.

CG Markgraf, S Kraydieh, R Prado, BD Watson… - Stroke, 1993 - Am Heart Assoc
… In the model describedby Markgraf et althe differences inthe volume of the brain lesions … in
Wistar rats the brain lesion (induced by the Markgraf method) does not fully mature until 3 or 4 …

Treatment window for hypothermia in brain injury

CG Markgraf, GL Clifton, MR Moody - Journal of neurosurgery, 2001 - thejns.org
Object. The goal of this study was to evaluate the therapeutic window for hypothermia
treatment following experimental brain injury by measuring edema formation and functional …

Benchmarking safety pharmacology regulatory packages and best practice

…, GS Friedrichs, MJ Kallman, C Markgraf… - … of Pharmacological and …, 2008 - Elsevier
… Survey topics included (a) an update on ICH S7A and S7B practices, (b) frontloading Safety
Pharmacology studies prior to selection of candidate drugs, (c) abuse and dependence-…

Safety pharmacology investigations on the nervous system: An industry survey

…, J Arezzo, MS Delatte, MJ Kallman, C Markgraf… - … of pharmacological and …, 2016 - Elsevier
The Safety Pharmacology Society (SPS) conducted an industry survey in 2015 to identify
industry practices as they relate to central, peripheral and autonomic nervous system (‘CNS’) …

Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat

CE Dixon, CG Markgraf, F Angileri, BR Pike… - Journal of …, 1998 - liebertpub.com
C) to improve outcome following severe traumatic brain injury in humans. The current
study examined whether hypothermia (32C) … Ten of the injured rats were cooled to 32C (measured …

Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats

…, WD Dietrich, F Van Dijk, R Busto, CG Markgraf… - Brain research, 1992 - Elsevier
… Animals were subjected to 12.5 min of four vessel occlusion (4VO) with moderate hypotension,
and brain temperature maintained at either 37C (4VO-37) or 30C (4VO-30). Behavioral …